More than 11,000 bottles of chlorthalidone have been recalled after testing revealed potential issues which may affect the drug’s effectiveness, the FDA says. Thousands of bottles of a popular blood pressure medication have been recalled nationwide due to a potential manufacturing issue that may affect how well the drug works. According to the U.S. Food and Drug Administration, more than 11,400 bottles of prescription chlorthalidone pills are affected. On June 5, the drug’s manufacturer, India-based Inventia Healthcare Limited, initiated a voluntary recall of certain lots of its 25-mg chlorthalidone tablets. The recalled 100-count and 1,000-count bottles were distributed across the...